Highlights from Pharmaceutical Technology and BioPharm International
Pharmaceutical Analysis
Modernization of the Standards for Elemental Impurities (Pharmaceutical Technology)
Recent activity in standards-setting organizations has raised interest in the impact of testing for impurities that may enter the product before it is mined or harvested or even due to intentional use of some reagents. 
Parenterals
The Next Horizon: Single-Use Technologies for Finished Drug Product Manufacturing (Pharmaceutical Technology)
Biopharmaceutical production is an often discussed application for single-use technologies, but single-use technologies also have application for small-scale finished drug-product manufacturing for producing clinical-trial materials.
Chemical API Manufacturing
Gaining Stereoselectivity in Asymmetric Synthesis (Pharmaceutical Technology)
Researchers use inorganic catalysts as an alternative to biocatalysts in the selective conversion of sugars to produce chiral building blocks.
Solid Dosage, Semisolid, and Specialty Dosage Forms
University Research Centers Transfer Continuous Manufacturing Technology to Industry (Pharmaceutical Technology’s Equipment & Processing Report)
Engineering groups at Rutgers and MIT constructed solid-dosage continuous manufacturing lines and transferred the technology to pharmaceutical industry partners.
Biological API manufacturing
Viral Vaccine Manufacturing (BioPharm International)
Tony Hitchcock of Cobra Biologics discusses challenges posed by production of viral vectors for vaccines.
|
